Please login to the form below

Innovative Medicines Initiative

This page shows the latest Innovative Medicines Initiative news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

There is a substantial need for innovative new treatment options for osteoarthritis, as many patients are unable to find relief with currently available medicines and continue to suffer,” said Ken Verburg, ... Europe launches antimicrobial research

Latest news

Europe's public-private alliance targets pain management

Innovative Medicines Initiative (IMI) brings pharma together with academia and patient groups in underserved area. ... The EU’s Innovative Medicines Initiative (IMI) has launched a new project that will bring together small and large pharma companies,
Daily Brief: Immunotherapy combos dominate ASCO, Pharma's Brexit warning, Big data and prostate cancer

Today’s Select Committee Report is right - a Brexit ‘no deal’ would significantly damage public health, patient access to medicines and the UK’s leading pharmaceutical sector. ... The European Union’s Innovative Medicines Initiative (IMI) has
IMI calls for advancements in machine learning and digital clinical trials

The Innovative Medicines Initiative (IMI) is pursing the development of machine learning and digital clinical trials with its latest round of funding. ... The funding, which comes from the EU’s Horizon 2020 research and innovative programme, will also
The Harmony Alliance gathers to battle blood cancer

nd. general assembly based in Berlin, Germany last week, 120 representatives from the Innovative Medicines Initiative’s ( IMI) Harmony Alliance all gathered to discuss achievements and objectives surrounding blood cancer.
Novartis and Bayer among backers for European big data project

Novartis, Bayer, Servier and Vifor Pharma are among those participating in BigData@Heart, a five-year, 19m project supported by the Innovative Medicines Initiative (IMI). ... and personalised medicines through advanced analytics.

More from news
Approximately 4 fully matching, plus 46 partially matching documents found.

Latest Intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery

EPAD is co-funded by the Innovative Medicines Initiative (IMI) and Europe’s pharma industry organisation EFPIA, and 2019 will see the first patients being treated by this groundbreaking new alliance. ... It is testament to the company’s innovative
30 Women Leaders in UK Healthcare (part 2)

She made major scientific contributions to neuroscience R&D within the pharmaceutical industry at GlaxoSmithkline, and also championed the vision for the Stevenage Bioscience Catalyst and theEuropean Innovative Medicines Initiative (IMI).
A quest for innovative solutions

to more than 300 with the creation of PRISM (Patient Relevant Innovative Solutions Mission) which seeks out the nuggets of therapeutic value and delivery innovation. ... The innovative Medicines Initiative (IMI), with 5.3bn invested in 90 projects, is a
The world is our laboratory

In January we announced the start of phase I clinical trials in the UK and US, production of 400, 000 vaccine regimens and formation of Innovative Medicines Initiative-funded consortia to ... That said, there is a rising demand for innovative medicines
The Heart of the Matter 7: Reality Dawns

Likewise, European pharmacovigilance legislation implemented in 2012 means the European Medicines Agency (EMA) is now requesting post-marketing observational studies as part of its approval processes. ... In tandem, as the limitations of the

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

Innovative Medicines Initiative appoints executive director

Pierre Meulien joins from Genome Canada . Innovative Medicines Initiative (IMI) has named Pierre Meulien as executive director, effective from September. ... Commenting on his appointment, Meulien said: “I am delighted to have been selected to lead
IMI picks Ipsen's Marc de Garidel to chair governing board

He takes over from former UCB CEO Roch Doliveux. The Innovative Medicines Initiative (IMI) has picked Ipsen's Marc de Garidel to take over as chair of its governing board from ... Its second-phase IMI 2 programme aims to develop next generation vaccines,
IMI appoints new chair of scientific committee

Prof Maria Beatriz da Silva Lima has been elected chair of the Scientific Committee of the Innovative Medicines Initiative (IMI).
Hans Lennernas joins board of CMO Recipharm

Prof Lennernäs is currently a professor of biopharmaceuticals at Uppsala University in Sweden, where he manages an Innovative Medicines Initiative (IMI) project called OrBiTo, which aims to improve the delivery of ... We are very pleased to welcome a